Conversion From Twice-Daily to Once-Daily Tacrolimus Among Egyptian Living-Donor Kidney Allograft Recipients: A Single-Center Experience.
CONCLUSIONS: Conversion from conventional tacrolimus (twice daily) to once-daily tacrolimus may be a valuable option with comparable patient and graft survival and may lead to improved adherence that may be reflective of better long-term results. It should be considered for de novo immunosuppression among living-donor renal allotransplant recipients.
PMID: 31050617 [PubMed - as supplied by publisher]
Source: Experimental and Clinical Transplantation : official journal of the Middle East Society for Organ Transplantation - Category: Transplant Surgery Authors: Bakr MA, Nagib AM, Abbas MH, Donia AF Tags: Exp Clin Transplant Source Type: research
More News: Bone Graft | Egypt Health | Kidney Transplant | Kidney Transplantation | Middle East Health | Prograf | Study | Tacrolimus | Transplant Surgery | Transplants | Urology & Nephrology